Web Exclusives

Measuring Treatment Adherence to Oral Therapies in Patients with CLL
CLL Monthly MinutesLeukemia
Oral targeted therapies have revolutionized treatment for patients with CLL but ensuring that they are taken as prescribed is crucial to achieving optimal outcomes.
Recent Regulation of Copay Adjustment Programs
CLL Monthly MinutesLeukemia
Copay assistance coupons and copay adjustment programs put patients in the middle of healthcare cost-saving measures.
Welcome to the Multiple Myeloma Resource Navigator for Patients
Multiple Myeloma
This publication was created together with leading patient advocates who shared their experiences and insights, in the hope that it will help you connect with patient organizations and resources as you and your care partners navigate through your diagnosis and treatment. These patient organizations provide education and support to promote your health and well-being, and help with practical matters, logistics, and financial and legal concerns.
Why Every Patient with Cancer Needs a Strong Support System
Support Services
Every person with cancer can benefit from a support system that can help manage the physical and emotional aspects of cancer care, as well as help with daily struggles.
A Look at First-Line CLL Treatment in 2021
CLL Monthly MinutesLeukemia
Currently, many effective, well-tolerated treatments exist, with high expectations for new drugs and regimens to be developed and approved in the near future.
Analysis Shows Unmet Needs in Quality-of-Life Studies in Patients with CLL
CLL Monthly MinutesLeukemia
A literature review found a set of physical, psychological, social, and spiritual topics that could be used to better educate patients throughout their CLL treatment journey.
Reduced Efficacy of COVID-19 Vaccination in Immunocompromised Patients
CLL Monthly MinutesLeukemia
COVID-19 vaccination is generally safe for immunocompromised patients, including those with CLL, although the efficacy is substantially lower than in healthy individuals.
Early Results for a Promising New BCL-2 Inhibitor
CLL Monthly MinutesLeukemia
Cell-based assays and animal data suggest that ZN-d5 may be a tolerable and effective treatment for patients with leukemias and lymphomas.
Why It Helps to Share Your Cancer Story and How to Get Started
Sharing your cancer story can promote your sense of what’s truly important, giving you hope and strength in difficult times.
Treating Rare Cancers Can Be Hard: Why Genomic Testing Is Crucial
Genomic/Genetic TestingCholangiocarcinoma
Jim Palma and John Hopper, Co-Chairs of NORD Rare Cancer Coalition, explain the difference between genetic testing and genomic profile testing, and why all patients with rare cancers should have a genomic profile done to select the best treatment for them based on potential genomic alteration.
Page 4 of 24
Results 31 - 40 of 237

Subscribe to Conquer: the journey informed

Receive timely cancer news & updates, patient stories, and more.

Race or Ethnicity
Profession or Role
Primary Interest
Other Interests